LivaNova
London · Founded 1987
About LivaNova
LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. LivaNova’s advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients, healthcare professionals and healthcare systems. They are committed to improving the lives of patients and families who deal with chronic disease, and they support the healthcare professionals who dedicate their lives to helping them. LivaNova is also dedicated to the highest standards, and they operate at the topmost level of business ethics and compliance. As a strong, market-leading medical technology and solutions company, they understand the importance of bringing both clinical and economic value to their customers. LivaNova offers a diverse product portfolio with a differentiated pipeline. Their global reach is broad with a presence in more than 100 countries and approximately 4,000 employees.
Company Facts
- Founded: 1987
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $1M – $10M
- Total funding: $300.0M
- Funding stage: IPO
- Last round: Post-IPO Debt (Mar 2024)
- Ticker: nasdaq:LIVN
- Website: livanova.com
- Phone: +44 281-228-7200
Industries & Categories
Health Care, Medical Device, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/livanova-58945 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.